<?xml version="1.0" encoding="ISO-8859-1"?>
<?xml-stylesheet type="text/xsl" href="helma.xsl"?>
<xmlroot xmlns:hop="http://www.helma.org/docs/guide/features/database">
  <hopobject id="2432" name="Page" prototype="Page" created="1363280116832" lastModified="1542472551929">
  <hop:parent idref="0" prototyperef="Root"/>
    <http_browser>Mozilla/4.0 (compatible; MSIE 6.0; Windows NT 5.1; SV1)</http_browser>
    <lang>en-us</lang>
    <uri>bone-update</uri>
    <http_host>127.0.0.1:8080</http_host>
    <time type="date">17.11.2018 16:35:51 UTC</time>
    <pseudoparent idref="0" prototyperef="Root"/>
    <http_remotehost>127.0.0.1</http_remotehost>
    <hopsession>127.0.0.144ml7g9hz86z</hopsession>
    <user>default</user>
    <pvcount type="float">85.0</pvcount>
    <body>How long are you planning to stay here? &lt;a href=&quot;https://www.mcmpovos.com/stmap_62bd0.html?glucotrol.escitalopram.levitra.desmopressin&quot;&gt;oxytocin hormone in hindi&lt;/a&gt;  Non-executive directors in an unregulated parent undertaking or holding company whose decisions or actions are regularly taken into account by the governing body of the UK authorised firm are required to have approval as a CF2 non-executive director within the approved persons regime. Those performing an executive function at the parent entity need to be approved as a CF1 director for the subsidiary company. In all cases the UK-regulated firm will be responsible for applying for the approvals. This is the case wherever the parent is located.
 </body>
    <http_language>en-US,en;q=0.8</http_language>
    <is_xhtml type="boolean">true</is_xhtml>
    <http_referer>http://beagleboard.org/bone-update/edit</http_referer>
  </hopobject>
</xmlroot>
